|
Tuesday, March 23 — 8:00 AM — Salon 2
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section A - Genitourinary Pathology
Chaired By: Thomas Ulbright and Ming Zhou
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
ERG Rearrangement Is Specific to Prostate Cancer and Does Not Occur in Any Other Common Epithelial Tumour
(970)
VJ Scheble, M Braun, C Ruiz, T Wilbertz, AC Stiedl, K Petersen, M Reischl, F Fend, G Kristiansen, L Bubendorf, M Rubin, S Perner. - University Hospital of Tuebingen, Tuebingen, Germany; University Hospital Basel, Basel, Switzerland; University Hospital Zurich, Zurich, Switzerland; Weill Cornell Medical College, New York, NY; Research Center Karlsruhe, Karlsruhe, Germany.
|  Add |
| 8:15 |
Prevalence of TMPRSS2-ERG and SLC45A3-ERG Gene Fusions in a Large Prostatectomy Cohort
(836)
R Esgueva, S Perner, CJ LaFargue, V Scheble, C Stephan, M Lein, FR Fritzsche, M Dietel, G Kristiansen, MA Rubin. - Weill Cornell Medical College, New York, NY; Comprehensive Cancer Center, University Hospital of Tuebingen, Tuebingen, Germany; University Hospital of Berlin, Berlin, Germany; Institute of Surgical Pathology, Zurich, Switzerland; Institute of Pathology, Charite, Berlin, Germany
| Add |
| 8:30 |
Molecular Pathways Associated with ERG Rearranged PTEN Deleted Hormone Refractory Prostate Cancer
(774)
M Alshalalfa, A Bakkar, K Sircar, JA Squire, R Alhajj, TA Bismar. - University of Calgary, Calgary, AB, Canada; University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada; MD Anderson Cancer Center, Houston, TX; Queens University and Kingston Hospital, Kingston, ON, Canada.
| Add |
| 8:45 |
Primary Leiomyosarcoma of the Kidney: A Clinicopathologic Study of 27 Cases
(919)
JS Miller, M Zhou, F Brimo, CC Guo, JI Epstein. - Johns Hopkins Hospital, Baltimore; Cleveland Clinic, Cleveland; MD Anderson Cancer Center, Houston.
| Add |
| 9:00 |
Nephroblastomas in Postpubertal Patients
(787)
JH Barton, IA Sesterhenn, B Furusato. - Armed Forces Institute of Pathology, Washington, DC; Center for Prostate Disease Research, Rockville, MD.
| Add |
| 9:15 |
Intravenous Dissection, the Optimum Strategy for Staging of Renal Cell Carcinoma
(796)
SM Bonsib, A Bhalodia. - Louisiana State University Helath Science Center, Shreveport, LA.
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
The RB/p16 Pathway but Not p53 Is Disrupted by High Risk HPV in Penile Squamous Cell Carcinoma
(985)
E Stankiewicz, DM Prowse, J Cuzick, L Ambroisine, S Kudahetti, N Watkin, C Corbishley, DM Berney. - Queen Mary, University of London, London, United Kingdom; St George's Hospital, London, United Kingdom.
| Add |
| 11:15 |
Should Pathologists Continue To Use the Current pT2 Substaging System for Reporting of Radical Prostatectomy Specimens?
(791)
A Billis, L Meirelles, LLL Freitas, LA Magna, U Ferreira. - School of Medicine, University of Campinas (Unicamp), Campinas, Brazil.
| Add |
| 11:30 |
An In-Depth Study of Extraprostatic Extension and Margin Status in Radical Prostatectomies
(807)
S Chan, F Garcia, M Moussa, J Chin, M Gabril. - LHSC/UWO, London, ON, Canada.
| Add |
| 11:45 |
Clinicopathologic Analysis of Vesicourethral Anastomosis Biopsy after Radical Prostatectomy: Correlation with Systemic Progression
(955)
JP Reynolds, JC Cheville, RJ Karnes, RE Jimenez. - Mayo Clinic, Rochester, MN.
| Add |
|
|
